Cancer cells overexpressing CXCR4 and CD133 were evaluated in fresh primary human ovarian cancer revealing extremely variable levels of CXCR4+/CD133+ and CD24+/CD44+ positive cells, without significant differences among the group of patients. This evidence concerns the gene PROM1 and ovarian carcinoma.